If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.
Peptides have gained significant attention in research due to their possible role in regulating various physiological ...
Even well-known drugs can cause entirely unpredictable effects on metabolism, Swiss researchers have shown. Rapidly mapping ...
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...
Demand for the hormone is surging, and not just to treat libido. Here’s what we know about its benefits, and potential risks.
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果